Chapter 1 A Method in Enzymology for Measuring Hydrolytic Activities in Live Cell Environments

Methods in Enzymology

Volumn 450, Issue , 2008, Pages 1-19

  Packard, Beverly Z ^a   Komoriya, Akira ^a  

^a OncoImmunin Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROLASE; INTERLEUKIN 1BETA CONVERTING ENZYME; NUCLEASE; PROTEINASE; FLUORESCENT DYE; PEPTIDE HYDROLASE;

CELL MEMBRANE PERMEABILITY; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME SPECIFICITY; ENZYMOLOGY; HYBRIDIZATION; MACROPHAGE; PRIORITY JOURNAL; REVIEW; ANIMAL; ARTICLE; CANCER INVASION; CELL LINE; CONFOCAL MICROSCOPY; HYDROLYSIS; METABOLISM; METASTASIS; MOUSE; NUCLEIC ACID HYBRIDIZATION;

ANIMALS; CELL LINE; CELL MEMBRANE PERMEABILITY; ENZYME ACTIVATION; FLUORESCENT DYES; HYDROLYSIS; MACROPHAGES; MICE; MICROSCOPY, CONFOCAL; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NUCLEIC ACID HYBRIDIZATION; PEPTIDE HYDROLASES; SUBSTRATE SPECIFICITY;

EID: 58249083310     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(08)03401-0     Document Type: Review

References (51)

1. Barber D.L., Wherry E.J., and Ahmed R. Cutting edge: Rapid in vivo killing by memory CD8 T cells. J. Immunol. 171 (2003) 27-31
2. Bell J.K., Goetz D.H., Mhrus S., Harris J.L., Fletterick R.J., and Craik C.S. The oligomeric structure of human granzyme A is a determinant of its extended substrate specificity. Nat. Struct. Biol. 10 (2003) 527-534
3. Bortner C.D., and Cidlowski J.A. Caspase independent/dependent regulation of K(+), cell shrinkage, and mitochondrial membrane potential during lymphocyte apoptosis. J. Biol. Chem. 274 (1999) 21953-21962
4. Bozhkov P.V., Filonova L.H., Suarez M.F., Helmersson A., Smertenko A.P., Zhivotovsky B., and von Arnold S. VEIDase is a principal caspase-like activity involved in plant programmed cell death and essential for embryonic pattern formation. Cell Death Differ. 11 (2004) 175-182
5. Chang S.H., Harvey K.J., Cvetanovic M., Komoriya A., Packard B.Z., and Ucker D.S. The effector phase of physiological cell death relies exclusively on the posttranslational activation of resident components. Exp. Cell Res. 277 (2002) 15-30
6. + T cell ratios in aviremic HIV-1-infected individuals receiving long-term highly active antiretroviral therapy. J. Infect. Dis. 85 (2002) 1672-1676
7. Ekert P.G., Silke J., and Vaux D.L. Inhibition of apoptosis and clonogenic survival of cells expressing crmA variants: Optimal caspase substrates are not necessarily optimal inhibitors. EMBO J. 18 (1999) 330-338
8. Felsenstein K.M., Hunihan L.W., and Roberts S.B. Altered cleavage and secretion of a recombinant beta-APP bearing the Swedish familial Alzheimer's disease mutation. Nat. Genet. 6 (1994) 251-255
9. Finucane D.M., Bossy-Wetzel E., Waterhouse N.J., Cotter T.G., and Green D.R. Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL. J. Biol. Chem. 274 (1999) 2225-2233
10. Guedez L., Stetler-Stevenson W.G., Wolff L., Wang J., Fukushima P., Mansoor A., and Stetler-Stevenson M. In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J. Clin. Invest. 102 (1998) 2002-2010
11. Harris J.L., Peterson E.P., Hudig D., Thornberry N.A., and Craik C.S. Definition and redesign of the extended substrate specificity of granzyme B. J. Biol. Chem. 273 (1998) 27364-27373
12. Harvey K.J., Lukovic D., and Ucker D.S. Caspase-dependent Cdk activity is a requisite effector of apoptotic death events. J. Cell Biol. 148 (2000) 59-72
13. Hirata H., Takahashi A., Kobayashi S., Yonehara S., Sawai H., Okasaki T., Yamamoto K., and Sasada M. Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J. Exp. Med. 187 (1998) 587-600
14. Huppertz B., Frank H.-G., Reister F., Kingdom J., Korr H., and Kaufmann P.P. Apoptosis cascade progresses during turnover of human trophoblast: Analysis of villous cytotrophoblast and syncytial fragments in vitro. Lab. Invest. 79 (1999) 1687-1702
15. Huppertz B., Frank H.-G., and Kaufmann P. The apoptosis cascade-Morphological and immunohistochemical methods for its visualization. Anat. Embryol. 200 (1999) 1-18
16. Johnson B.W., Cepero E., and Boise L.H. Bcl-xL inhibits cytochrome c release but not mitochondrial depolarization during the activation of multiple death pathways by tumor necrosis factor-alpha. J. Biol. Chem. 275 (2000) 31546-31553
17. Kanuka H., Hisahara S., Sawamoto K., Shoji S., Okano H., and Miura. Proapoptotic activity of Caenorhabditis elegans CED-4 protein in Drosophila: Implicated mechanisms for caspase activation. Proc. Natl Acad. Sci. USA 96 (1999) 145-150
18. Komoriya A., Packard B.Z., Brown M.J., Wu M.-L., and Henkart P.A. Assessment of caspase activities in intact apoptotic thymocytes using cell-permeable fluorogenic caspase substrates. J. Exp. Med. 191 (2000) 1819-1828
19. Liu L., Chahroudi A., Silvestri G., Wernett M.E., Kaiser W.J., Safrit J.T., Komoriya A., Altman J.D., Packard B.Z., and Feinberg M.B. Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates. Nat. Med. 8 (2002) 185-189
20. Liu L., Packard B.Z., Brown M.J., Komoriya A., and Feinberg M.B. Assessment of lymphocyte-mediated cytotoxicity using flow cytometry. Methods Mol. Biol. 263 (2004) 125-140
21. Lukovic D., Komoriya A., Packard B.Z., and Ucker D.S. Caspase activity is not sufficient to execute cell death. Exp. Cell Res. 289 (2003) 384-395
22. Mariathasan S., Newton K., Monack D.M., Vucic D., French D.M., Lee W.P., Roose-Flrma M., Erickson S., and Dixit V.M. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430 (2004) 213-218
23. Metkar S.S., Wang B., Ebbs M.L., Kim J.H., Lee Y.J., Raja S.M., and Froelich C.J. Granzyme B activates procaspase-3 which signals a mitochondrial amplification loop for maximal apoptosis. J. Cell Biol. 160 (2003) 875-885
24. Mook O.R., Frederiks W.M., and Van Noorden C.J. The role of gelatinases in colorectal cancer progression and metastasis. Biochim. Biophys. Acta 1705 (2004) 69-89
25. Mullan M., Crawford F., Axelman K., Houlden H., Lilius L., Winblad B., and Lannfelt L. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat. Genet. 1 (1992) 345-347
26. Nicholson D.W., and Thornberry N.A. Caspases: Killer proteases. Trends Biochem. Sci. 22 (1997) 299-307
27. Nomura T., and Katunuma N. Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells. J. Med. Invest. 52 (2005) 1-9
28. Packard B.Z., Toptygin D.D., Komoriya A., and Brand L. Profluorescent protease substrates: Intramolecular dimers described by the exciton model. Proc. Natl Acad. Sci. USA 93 (1996) 11640-11645
29. Packard B.Z., Toptygin D.D., Komoriya A., and Brand L. Design of profluorescent protease substrates guided by exciton theory. Methods Enzymol. 278 (1997) 15-28
30. Packard B.Z., Komoriya A., Toptygin D.D., and Brand L. Structural characteristics of fluorophores that form intramolecular H-type dimers in a protease substrate. J. Phys. Chem. B 101 (1997) 5070-5074
31. Packard B.Z., Toptygin D.D., Komoriya A., and Brand L. Characterization of fluorescence quenching in bifluorophoric protease substrates. Biophys. Chem. 67 (1997) 167-176
32. Packard B.Z., Toptygin D.D., Komoriya A., and Brand L. Intramolecular resonance dipole-dipole interactions in a profluorescent protease substrate. J. Phys. Chem. B 102 (1998) 752-758
33. Packard B.Z., Komoriya A., Nanda V., and Brand L. Intramolecular excitonic dimers in protease substrates: Modification of the backbone moiety to probe the H-dimer structure. J. Phys. Chem. B 102 (1998) 1820-1827
34. Packard B.Z., Komoriya A., Brotz T.M., and Henkart P.A. Caspase 8 activity in membrane blebs after anti-Fas ligation. J. Immunol. 167 (2001) 5061-5066
35. Packard B.Z., Telford W.G., Komoriya A., and Henkart P.A. Granzyme B activity in target cells detects attack by cytotoxic lymphocytes. J. Immunol. 179 (2007) 3812-3820
36. Packard B.Z., Artym V.V., Komoriya A., and Yamada K.M. Direct visualization of protease activity on cells migrating in three dimensions. Matrix Biol. (2008) (in press)
37. Patten L.C., and Berger D.H. Role of proteases in pancreatic carcinoma. World J. Surg. 29 (2005) 258-263
38. Richardson P.L. The determination and use of optimized protease substrates in drug discovery and development. Curr. Pharm. Design 8 (2002) 2559-2581
39. Robles R., Tao X.-J., Trbovich A.M., Maravei D.V., Nahum R., Perez G.L., Tilly K.L., and Tilly J.L. Localization, regulation and possible consequences of apoptotic protease-activating factor-1 (Apaf-1) expression in granulosa cells of the mouse ovary. Endocrinology 140 (1999) 2641-2644
40. Scaffidi C.S., Fulda S., Srinivasan A., Friesen C., Li F., Tomaselli K.J., Dabatin K.M., Krammer P.H., and Peter M.E. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17 (1998) 1675-1687
41. Silverman G.A., Bird P.I., Carrell R.W., Church F.C., Coughlin P.B., Gettins P.G., Irving J.A., Lomas D.A., Luke C.J., Moyer R.W., Pemberton P.A., Remold-O'Donnell E., et al. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J. Biol. Chem. 276 (2001) 33293-33296
42. Skrzydlewska E., Sulkowska M., Koda M., and Sulkowski S. Proteolytic-antiproteolytic balance and its regulation in carcinogenesis. World J. Gastroenterol. 11 (2005) 1251-1266
43. Song H.K., Lee K.N., Kwon K., Yu M., and Suh S.W. Crystal structure of an uncleaved alpha 1-antitrypsin reveals the conformation of its inhibitory reactive loop. FEBS Lett. 377 (1995) 150
44. Stennicke H.R., Jurgensmeier J.M., Shin H., Deveraux Q., Wolf B.B., Yang X., Zhou Q., Ellerby H.M., Ellerby L.M., Bredesen D., Green D.R., Reed J.C., et al. Pro-caspase-3 is a major physiologic target of caspase-8. J. Biol. Chem. 273 (1998) 27084-27090
45. Strasser A., O'Connor L., and Dixit V.M. Apoptosis signaling. Annu. Rev. Biochem. 69 (2000) 217-245
46. Telford W.G., Komoriya A., and Packard B.Z. Detection of localized caspase activity in early apoptotic cells by laser scanning cytometry. Cytometry 47 (2002) 81-88
47. Telford W.G., Komoriya A., and Packard B.Z. Multiparametric analysis of apoptosis by flow and image cytometry. Methods Mol. Biol. 263 (2004) 141-160
48. Thornberry N.A., Rano T.A., Peterson E.P., Rasper D.M., Timkey T., Garcia-Calvo M., Houtzager V.M., Nordstrom P.A., Roy S., Vaillancourt J.P., Chapman K.T., and Nicholson D.W. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272 (1997) 17907-17911
49. Vihinen P., Ala-aho R., and Kahari V.M. Matrix metalloproteinases as therapeutic targets in cancer. Curr. Cancer Drug Targets 5 (2005) 203-220
50. Wei L., and Shi Y.B. Matrix metalloproteinase stromelysin-3 in development and pathogenesis. Histo. Histopathol. 20 (2003) 177-185
51. Zapata J.M., Takahashi R., Salvesen G.S., and Reed J.C. Granzyme release and caspase activation in activated human T-lymphocytes. J. Biol. Chem. 273 (1998) 6916-6920